Bansi Nagji Advocates for Precision and Personalized Care in Rare Disease Pharmacy Model

Bansi Nagji, Chief Executive Officer at PANTHERx Rare, has highlighted the distinct challenges and requirements of rare disease pharmacy in a recent discussion. He emphasized that the traditional pharmacy model does not adequately address the needs of patients with rare diseases, advocating for a specialized approach built around precision, speed, and personalized care. Nagji urged manufacturers and stakeholders to reconsider their strategies to better support the unique demands of these patient journeys.

Rare disease pharmacies operate under a fundamentally different framework compared to conventional pharmacies. According to Nagji, this model prioritizes hyper-personalized care tailored to individual patients, ensuring timely access to medications and services critical for managing complex conditions. He stressed that addressing these needs requires collaboration among pharmaceutical manufacturers and healthcare stakeholders to develop solutions that align with the specific challenges faced by rare disease patients and their caregivers. Additional insights from PANTHERx patients and caregivers provide firsthand perspectives on living with rare diseases, further illustrating the importance of specialized pharmacy support in improving patient outcomes.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: March 27, 2026

Author

GOAI